Acute therapeutic management of M1-middle cerebral artery occlusion with underlying intracranial atherosclerotic disease: is mechanical thrombectomy the right first-line choice?
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background Acute occlusions of the anterior circulation with an underlying intracranial atheromatous disease (ICAD) represent a diagnostic and therapeutic challenge. The aim of this study was to compare the results of the endovascular treatment (EVT) ± intravenous thrombolysis (IVT) and the best medical treatment (BMT ± IVT) as first-line approach in a cohort of patients with certain diagnosis of M1-Middle Cerebral Artery (M1-MCA) occlusions and underlying ICAD. Methods Patients with M1-MCA and a certain diagnosis of underlying ICAD were included in this retrospective, monocentric analysis between 2018 and April 2023. Baseline, procedural and clinico-neuroradiological follow-up data were collected. EVT ± IVT and BMT ± IVT were the two study groups. An independent core lab assessed the imaging data. The primary outcome was the rate of functional independence at 3 months (mRS0-2); secondary outcomes included the extension of the ischemic lesion (∆baseline-24 hours volume), the early neurological deterioration (END), the rate of symptomatic intracranial haemorrhages (sICH). Results Thirty-four patients were included in the study (65,7 ± 16,5 y.o.; males: 52,8%), 23 were treated by EVT ± IVT and 11 with BMT ± IVT. Functional independence was less frequent in the EVT ± IVT group compared to the BMT ± IVT (26%vs81,8%, p = 0,003). The increase of ∆ volume, the rate of END and sICH were significantly lower in the BMT ± IVT group. Conclusions EVT ± IVT (only MT) was associated with worse clinical and neuroimaging outcomes compared to BMT ± IVT. Nevertheless, a beneficial effect of primary angioplasty ± stenting should be taken in account and future studies will be necessary to investigate this therapeutic option.
